Clinical Trial Update: Levosimendan in Acute Decompensated Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

This document reports on a phase 2/3 clinical trial evaluating levosimendan for acute decompensated heart failure, with the trial currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Chittagong Medical College | Conditions: Acute Decompensated Heart Failure (ADHF) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING